Skip to main content

Table 1 STARD checklist for the reporting of studies of diagnostic accuracy (shortened item description)

From: A systematic review of the literature examining the diagnostic efficacy of measurement of fractionated plasma free metanephrines in the biochemical diagnosis of pheochromocytoma

Selection and topic

Item

Mayo

NIH

Vienna

  

R1*

R2*

R1*

R2*

R1*

R2*

TITLE/ABSTRACT

1. Identify study of diagnostic accuracy

•

•

•

•

•

•

INTRODUCTION

2. State the research question

•

•

•

•

•

•

METHODS

       

Participants

3. Describe study population

•

•

•

•

•

•

 

4. Describe participant recruitment

•

•

•

•

  
 

5. Describe participant sampling

•

•

 

•

  
 

6. Describe if prospective or retrospective

•

•

•

•

 

•

Test Methods

7. Reference standard and rationale

•

•

•

•

•

•

 

8. Technical specifications described or referenced

•

•

•

•

•

•

 

9. Description of rationale for cut-offs for index tests and reference standards

•

•

 

•

•

•

 

10. Description of the number and training of persons executing the tests

      
 

11. Description of blinding of test readers

      

Statistical Methods

12. Description of calculations of diagnostic accuracy and uncertainty

•

•

•

•

•

•

 

13. Description of calculations of test reproducibility

     

•

RESULTS

       

Participants

14. Description of duration of study

•

•

•

•

  
 

15. Description of clinical and demographic description of participants

•

•

•

•

•

•

 

16. Description of the number of participants satisfying inclusion criteria that did not undergo the index test or reference standard, and why

  

•

•

  

Test Results

17. Description of the time interval from the index test to the reference standard and any treatment administered between

      
 

18. Description of the severity of disease in those with the target condition; other diagnoses in participants without the target condition

•

 

•

 

•

 
 

19. A cross-tabulation of the results of the index tests (including indeterminate and missing tests)

•

•

•

•

•

•

 

20. Any adverse events from performing the index or reference tests

      

Estimates

21. Estimates of diagnostic accuracy with statistical uncertainty

•

 

•

 

•

 
 

22. Description of how indeterminate results were handled

•

•

    
 

23. Estimates of variability between subgroups of patients, readers, or centres

•

•

•

•

  
 

24. Estimates of test reproducibility

     

•

DISCUSSION

25. Discussion of the clinical applicability of the findings

•

•

•

•

•

•

  1. *R1 and R2, refer to Reviewer 1 and 2, •indicates criteria fulfilled (at least in part)